Market research reports on: Medical devices, diagnostics, tissue, surgical, biopsy, MRI, mobile health, orthopedic, monitoring, laboratory, telemedicine, endoscope and others.
Let's ConnectBiochip: Global Markets to 2023
The global biochips market should reach $27.3 billion by 2023 from $6.9 billion in 2018 at a compound annual growth rate (CAGR) of 31.8% for the period of 2018-2023.
Atrial Fibrillation: Technologies and Global Markets
The global market for atrial fibrillation devices should grow from $4.1 billion in 2018 to $7.8 billion by 2023 at a compound annual growth rate (CAGR) of 13.6% for the period of 2018-2023.
Blood Testing: Technologies and Global Markets
The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.
Technologies for Long-term Care and Home Healthcare: Global Marke...
The global market for elder care technologies should grow from $5.7 billion in 2017 to $13.6 billion by 2022 at a compound annual growth rate (CAGR) of 19.2% from 2017 through 2022.
Medical Ultrasound Devices: Technologies and Global Markets
The global market for medical ultrasound devices will grow from $6.7 billion in 2018 to $7.8 billion by 2023 with a compound annual growth rate (CAGR) of 3.0% for the period of 2018-2023.
Assistive Devices for Special Needs: Technologies and Global Mark...
The global market for assistive devices for special needs reached nearly $15.9 billion in 2018 and should reach $20.1 billion by 2023, at a compound annual growth rate (CAGR) of 4.9% for the period of 2018-2023.
Medical Tourism: Market Outlook and Trends
Medical tourism is considered the direct impact of the globalization of healthcare and it has the potential for strong growth globally. It has presented new opportunities and benefits to individuals looking for medical treatment abroad. The medical tourism industry has presented countries with low cost and high-income possibilities leading the countries to plan and develop this section of the tourism industry. Affordability and accessibility of healthcare services offered by medical tourism has spiked the market growth.
Dental Implants: Global Markets to 2023
The global market for dental implants reached $3.6 billion in 2018 and should reach nearly $5.0 billion by 2023, at a compound annual growth rate (CAGR) of 6.5% for the period of 2018-2023.
Endovascular Treatment Devices: EVAR and TEVAR Emphasis
The global market for endovascular treatment devices reached $2.0 billion in 2017 and should reach nearly $2.8 billion by 2022, at a compound annual growth rate (CAGR) of 7.3% from 2017 to 2022.
Single Blood Drop Analysis: Technologies and Global Market
The global market for single blood drop analysis will grow from $9.2 billion in 2017 to $25.1 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022.
Cosmetic and Personal Care Stores: Global Markets to 2022
The global cosmetic and personal care stores market totaled $75.3 billion in 2017 and is estimated to reach $100.7 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.0% for the period of 2017-2022.
Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2...
The global ovarian cancer therapeutic market reached $2.1 billion in 2017. The market should reach $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.1% during 2017-2022.
Fluoroscopy and C-arms: Technologies and Global Markets
The global market for fluoroscopy and C-arms reached $2.2 billion in 2017 and should reach nearly $2.7 billion in 2022 at a compound annual growth rate (CAGR) of 3.8% for the period of 2017-2022.
Global Markets and Technologies for Electronic Health Records
The global market for electronic health records totaled $22.0 billion in 2017 and is estimated to reach $39.1 billion by 2022, growing at a compound annual growth rate (CAGR) of 12.2% for the period of 2017-2022.
Cardiovascular Devices: Global Markets to 2022
The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and should reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Healthcare Cloud Computing: Global Markets to 2022
The global market for cloud technologies in healthcare was $16.1 billion in 2016. The market should reach $20.2 billion in 2017 and $35.0 billion by 2022, growing at a compound annual growth rate (CAGR) of 11.6% during 2017-2022.
Healthcare Analytics: Technologies and Global Markets
The global market for healthcare analytics reached $6.2 billion in 2016. This market should reach nearly $7.2 billion in 2017 and $14.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.8%.
Biologic and Medical Imaging Reagents: Global Markets
The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022.
Medical Device Security: Technologies and Global Markets
The global market for medical device security totaled $4.7 billion in 2016. The market should total $5.2 billion in 2017 and $7.5 billion by 2022, increasing at a compound annual growth rate (CAGR) 7.4% from 2017 to 2022.
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostics was valued at $107.4 billion in 2016. This market is estimated to grow from nearly $114.6 billion in 2017 to $159.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Laboratory-developed Testing: Technologies and Markets
The global market for laboratory-developed tests reached nearly $9.7 billion in 2015. This market is expected to increase from nearly $11.0 billion in 2016 to $14.9 billion in 2021 at a compound annual growth rate (CAGR) of 6.3% for 2016-2021.
The Global Blood Industry
The global sales of blood products reached $31.8 billion in 2015 and $33.5 billion in 2016. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.9% from 2016 to 2021, reaching nearly $42.6 billion in 2021.
Biosurgery: Technologies and Global Markets
The global biosurgery market should reach $12.5 billion by 2021 from $8.3 billion in 2016 at a compound annual growth rate (CAGR) of 8.5%, from 2016 to 2021.
Photomedicine: Technologies and Global Markets
The global photomedicine technology market will grow from $346 million in 2016 to $436 million by 2021, with a compound annual growth rate (CAGR) of 4.7% for the period of 2016-2021.
Spinal Intervention: Markets for Surgical, Replacement and Neuros...
The global market for spinal and neurostimulation intervention products is expected to reach $15.8 billion by 2021 from $12.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 4.5% from 2016 through 2021.
Choose your License
Conventional and Alternative Pain Treatment Markets
This report provides an in-depth analysis of the conventional and alternative pain treatment markets, including market estimations and projections through 2029.
Surgical Equipment: Technologies and Global Markets
This research report comprehensively analyzes the surgical equipment market, including forecasts and sales projections through 2029. It covers key market players, detailed product segments, supporting technologies, trends, market dynamics, competitive intelligence, and regional trends.
OTC Drugs, Medical Devices and Diagnostics: Global Markets
This report comprehensively covers the global OTC drugs, medical devices, and diagnostics market, presenting quantitative and qualitative data.
In Vitro Diagnostics: Technologies and Global Markets
This report incorporates an in-depth analysis of the In vitro diagnostics technologies and global markets, including market estimations and trends through 2029. Major players, competitive intelligence, innovative & emerging technologies, market dynamics and regional opportunities are discussed in detail.
Biologic and Medical Imaging Reagents: Global Markets
This report includes the biological imaging reagents that are already commercialized or likely to be commercialized within the next five years. Fluorescent probes and dyes; imaging nanomaterials; fluorescent proteins; contrast reagents for MRI, X-ray and ultrasound; and imaging radiopharmaceuticals are included in this report.